Luminex is seeking abstract submissions for poster presentations at xMAP® Connect 2018. Please submit your abstract to the left. Please follow the guidelines below and use this outline.
Abstract text should include all the items listed below and is limited to 3,000 characters (approximately 500 words) not including spaces:
If you have any questions about xMAP Connect, email europe@luminexcorp.com.
Click here to learn more about xMAP Connect 2018 in Amsterdam.
* By submitting an abstract, you agree to the following terms and conditions:
I agree to be present the 8th and 9th of November in Amsterdam, should your abstract be selected.
This submission has been approved by all authors and serves to grant Luminex an irrevocable license to use the abstract and poster in connection with the xMAP Connect meeting. The authors accept sole responsibility for the statements in their abstracts. The authors are submitting an original abstract and, if selected, will present an original poster with accompanying media figures during the xMAP Connect meeting. The authors warrant this content is their own creation and is 100% original work; is not subject to, and does not infringe upon, the rights of any third parties, including without limitation privacy or publicity rights; and is not defamatory, obscene, or otherwise illegal. If “non-original” text or media of any kind is used, the authors certify permission has been granted by the authors, creators, or publishers of that content.
Selected abstracts must meet minimum Luminex assay quality criteria. Abstracts will be evaluated on the basis of: impact to the field, scientific content, concept/novelty, use of techniques, and value to the scientific community. The submissions meeting these criteria will be selected to present posters during the xMAP Connect meeting.
Entrants not complying with the above requirements will be subject to disqualification.
| Accepted Posters | |
| Number | Abstract |
| 1 | Stephan Michalik xMAP® – An App to Analyze, Visualize, and Inspect Dilution-base Serological Assay Using the xMAP Technology View Abstract |
| 2 | Premnath Rajakannu Multiplexing Protein and Gene Level Measuements on a Single Luminex Platform View Abstract |
| 3 | Tatiana Suslova Detection of Cytokines and Chemokines in Supernatants and Blood Serum of Patients with Diabetes Mellitus Type 2 by Multiplex Analysis View Abstract |
| 4 | Anna Gusakova Application of the Multiplexed Immunoassays in the Comprehensive Assessment of Cardiovascular Biomarkers Dynamics in Patients with Acute Primary Anterior Myocardial Infarction with ST Segment Elevation View Abstract |
| 5 | Laurie Stephen Stability of Zika and Dengue Immunoglobulines in Matched Serum and Uring Samples as Assessed Using a 15-plex Commercial Kit for the Detection IgG and IgM to Zika and Other Flaviviruses View Abstract |
| 6 | Mathilda Dale Designing Sandwich Assay Workflows for Large Scale Studies of Plasma Biobanks View Abstract |
| 7 | Richard K. Fuerstenberg (Bio-Techne) Improved Accuracy in Multiplex Assays by Elimination of False Positives Due to Endogenous Antibodies View Abstract |
| 8 | Scott Altmann Protein Dense Lipoproteins: The Unimagined Biomarker for Human Health Assessment View Abstract |
| 9 | Brooke Gilliam (Merck) Multiplex Immunoassay Detection of Autoimmune Disease Autoantibodies in Serum and Plasma View Abstract |
| 10 | Philippa Pettingill Generation of a Validated Suspension Bead Array Assay for Exploratory and High-throughput Profiling of Human Plasma View Abstract |
| 11 | Wen-Rong Lie (Merck) Quantitative Multiplex Analysis of Immune Checkpoint Protein Expression in Circulation and in the Tumor Microenvironment View Abstract |
| 12 | Siphesihle Mdlalose The Role of Folllistatin in HIV-associated Pre-eclampsia View Abstract |
| 13 | Helena Kupcova Skalnikova Profiling of Blood Cytokines in Melanoma Patients and Porcine Melanoma Model: Search for Positive/Negative Prognostic Markers View Abstract |
| 14 | Liza Portier Bead-based Multiplex Technology for the Simultaneous, Fast, and Portable On-site Detection of Different Food Contaminants View Abstract |
| 15 | Mansour Harsini Evaluation of Protein Biomarkers in Wound Fluid for Rediction Wound Healing in Diabetic Foot Ulcers by Luminex Assay View Abstract |
| 16 | Elizabeth Dreskin (Bio-Rad) Profiling Apolipoproteins in Disease View Abstract |
| 17 | Salvatore Pernagallo A Breakthrough PCR-free Technology for Diagnosing Liver Injury View Abstract |
| 18 | Csilla Nemes Identification of Potential Biomarkers Useful in Differentation COPD from Asthma View Abstract |
| 19 | Tadeja Kuret Development of a Novel Bead-based Luminex Assay for Simultaneous Detection of Autoantibodies Against Acute Phase Proteins View Abstract |
| 20 | Solveig Konings Cancer Immunotherapy Array: A Novel Screening Tool For Immune System Profiling in Cancer Immunotheraphy Bridging Autoimmunity and Cancer View Abstract |
| 21 | Jan Rožanc (ProtAtOnce) Multiplex Phosphoproteomic Profiling Predicts Trametinib Responsiveness and Optimal Trametinib Sensitization Strategies in Melanoma View Abstract |
| 22 | Christian Raue Is Your Data Normally Distributed? View Abstract |
| 23 | Natalia Lyubimova The Concentration of Some Chemokines in Blood Plasma in Healthy Donors View Abstract |
| 24 | Natalya Arsentieva Chemokines as the Biomarkers of Chronic Hepatitis with Different Etiology View Abstract |
| 25 | Tatiana Radygina Biomarkers of Biological Therapy Inefficiency in Children with Inflammatory Bowel Diseases View Abstract |
| 26 | Svetlana Apalko The Role of Multiplexed Assays in Characterizing Samples from the Clinical Biobank View Abstract |
| 27 | Abigail Bell Findings and Updates from the Multiplex Immunoassay Consortium View Abstract |
| 28 | Anastaciia Boiko Metabolic Syndrome of Patients with Schizophrenia and Spectrum of Apolipoproteins in Blood Serum View Abstract |
| 29 | Stefano Bonacci Development of an Integrated Luminex-Hamilton Platform for High-Throughput Multiplexed Immuno Assays View Abstract |
| 30 | Ezra Linley Should Pneumococcal Serotype 3 Be Included in Sero-Type Specific Immunoassays View Abstract |
| 31 | Wojciech Swidzinski Transforming Routine Laboratory Developed Tests Using Hydrolysis Probe Chemistry into Cassette Based Molecular Assays for use on the Luminex ARIES® System View Abstract |
| 32 | Sandra Mükusch Unraveling antibody specificity via multiple complementary approaches View Abstract |
| 33 | Séverine Giltaire Cytokine detection and measurement with Multiplex Technologies in the context of a cytokine secretion assay View Abstract |
| 34 | Ciska Lindelauf Cytokine profiles during the recovery phase of rituximab treatment in patients with interstitial pneumonitis View Abstract |
| 35 | Celine Merg The impact of exposure to cigarette smoke on the secreton of inflammatory mediators: assessment using human organotypic small airway epithelial cultures from five different donors View Abstract |
